- MOQ5 Box
- Country of OriginIndia
- Supply TypeExporter, Supplier, Retailer, Distributor
- Preferred Buyer Location All over the world
Hepcinat-Plus is used as a treatment for chronic hepatitis C virus (HCV) infection. It is a generic fixed-dose combination drug, which consists of Sofosbuvir 400 mg and Daclatasvir 60 mg. Natco Pharma is India’s first company to launch combination of Sofosbuvir+Daclatasvir in one tablet under its brand name Hepcinat-Plus.
Member Since 3 Years
Nature of Business Manufacturer
GST No. 27AAACZ1513C1ZT
For Buyer 
For Seller 
Help 
Bhosari, Pune, Maharashtra 